Which medications in the drug class Secretagogues are used in the treatment of Intestinal Motility Disorders?

Updated: Sep 16, 2020
  • Author: Mia L Manabat, DO; Chief Editor: Burt Cagir, MD, FACS  more...
  • Print


Lubiprostone (Amitiza)

Lubiprostone activates chloride channel-2 (ClC-2) chloride channels, increasing intestinal fluid secretion and motility, reducing intestinal permeabiliaty, and stimulating recovery of mucosal barrier function.

Linaclotide (Linzess)

Linaclotide activates guanylate cyclase-C, stimulating cGMP production and increasing intestinal fluid secretion and motility.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!